A pivotal trial of vaccines against the strain of Ebola that is driving a deadly outbreak across parts of Africa has begun in the Democratic Republic of Congo, where the epidemic originated and the vast majority of cases and deaths have occurred.
The first participant was vaccinated on Friday in Bunia, eastern DR Congo, with Merck & Co’s Ervebo shot, which has been approved to guard against a different Ebola species. An experimental alternative developed specifically against Bundibugyo by...
DR Congo begins pivotal Ebola vaccine trial as outbreak kills nearly 4,700
Global - Asia
Archived
•
October 25, 2026
•
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



